2019 CYIR Finalized
37 method, monitoring lactate clearance is widely used. There are limitations in interpretability of lactate clearance, and lactate measurements may not be readily measurable at all sites. It has been proposed that persistent peripheral perfusion abnormalities after resuscitation, measured by capillary refill time (CRT), might correlate with organ dysfunction and mortality. It is unknown whether bedside CRT might be used to monitor resuscitation in septic shock. This study randomized 424 adults with early septic shock in 28 ICUs across 5 countries to determine whether peripheral perfusion-targeted resuscitation is more effective than lactate-guided resuscitation. The peripheral perfusion-targeted resuscitation group aimed to normalize CRT, and the lactate-guided resuscitation group aimed to normalize or decrease lactate levels more than 20% over 2 hour-periods during the 8-hour intervention. There was no significant difference in the primary outcome of 28-day mortality between the two groups (34.9% peripheral perfusion vs. 43.4% lactate group, P=0.06). However, the peripheral perfusion group had less organ dysfunction at 72 hours than the lactate group (mean SOFA 5.6 vs. 6.6, P=0.045), with no significant differences in the other secondary outcomes. Comments 1. Peripheral perfusion-targeted resuscitation did not result in sta- tistically significant lower 28-day mortality than lactate-targeted resuscitation in early septic shock, although the study may have been underpowered to detect a meaningful difference. 2. CRT can have inter-rater variability that was not assessed in this study, although investigators at all sites were trained to use a standardized protocol (i.e., CRT was assessed by applying pressure with a glass microscope slide to the right index finger distal ventral surface for 10 seconds, then time for return to nor- mal skin color was assessed with >3 sec refill time registered as abnormal). 3. The peripheral perfusion and lactate-guided groups were man- aged with an identical protocolized approach to resuscitation that included assessment of fluid responsiveness, followed by a vasopressor challenge that tested higher mean arterial pres- sure targets in patients with chronic hypertension, followed by inodilator testing; and higher vasopressors or inodilators were maintained only if the patients were deemed responsive to them. 4. Patients in the peripheral perfusion group received 408ml less fluid in the first 8 hours than the lactate-guided group. 5. Although there was no statistical difference in 28-day mortality between the peripheral perfusion and lactate-guided resuscita- tion groups, the study raises the intriguing possibility that a bedside assessment of CRT, that could potentially be applied in resource-poor settings, could play a role in guiding resuscita- tion in septic shock. OTHER ARTICLES OF INTEREST Management of Distributive/Septic Shock McIntyre WF, Um KJ, Alhazzani W, Lengyel A, Hajjar L, Gordon AC, Lamontagne F, Healey JS, Whitlock RP, Belley-Cote EP. Association of Vasopressin Plus Catecholamine Vasopressors vs Catecholamines Alone With Atrial Fibrillation in Patients with Distributive Shock. A Systematic Review and Meta-analysis. JAMA 2018; 319:1889-1900. Itenov TS, Johansen ME, Bestle M, Thormar K, Hein L, Gyldensted L, Lindhardt A, Christensen H, Estrup S, Pedersen HP, Harmon M, Soni UK, Perez-Protto S, Wesche N, Skram U, Petersen JA, Mohr T, Waldau T, Poulsen LM, Strange D, Juffermans NP, Sessler DI, Tønnesen E, Møller K, Kristensen DK, Cozzi-Lepri A, Lundgren JD, Jensen JU; Cooling and Surviving Septic Shock (CASS) Trial Collaboration. Induced hypothermia in patients with septic shock and respiratory failure (CASS): a random- ized, controlled, open-label trial. Lancet Respir Med 2018; 6:183-192. Sodium Bicarbonate Therapy in the ICU Jaber S, Paugam C, Futier E, Lefrant JY, Lasocki S, Lescot T, Pottecher J, Demoule A, Ferrandière M, Asehnoune K, Dellamonica J, Velly L, Abback PS, de Jong A, Brunot V, Belafia F, Roquilly A, Chanques G, Muller L, Constantin JM, Bertet H, Klouche K, Molinari N, Jung B; BICAR-ICU Study Group. Sodium Bicarbonate therapy for patients with severe metabolic acidemia in the intensive care unit (BICAR-ICU): a multicenter, open- label randomized controlled, phase 3 trial. Lancet 2018; 392: 31-40. Delirium Management in Critically Ill Patients van den Boogaard M, Slooter AJC, Brüggemann RJM, Schoonhoven L, Beishuizen A, Vermeijden JW, Pretorius D, de Koning J, Simons KS, Dennesen PJW, Van der Voort PHJ, Houterman S, van der Hoeven J, Pickkers P; REDUCE Study Investigators, van der Woude, Besselink A, Hofstra LS, Spronk PE, van den Bergh W, Donker DW, Fuchs M, Karakus A, Koeman M, van Duijnhoven M, Hannink G. Effect of Haloperidol on Survival Among Critically Ill Adults with a High Risk of Delirium: The REDUCE Randomized Clinical Trial. JAMA 2018; 319:680-690. Skrobik Y, Duprey MS, Hill NS, Devlin JW. Low-Dose Nocturnal Dexmedetomidine Prevents ICU Delirium. A Randomized, Placebo-controlled trial. Am J Respir Crit Care Med 2018; 197:1147-1156. GENERAL CRITICAL CARE
Made with FlippingBook
RkJQdWJsaXNoZXIy MTM1ODMw